Picture of Vext Science logo

VEXT Vext Science News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSuper Stock

Cannabis operator Vext's Q3 revenue up 41% on Ohio expansion

Overview

Vext Q3 2025 revenue grows 41% YoY, driven by Ohio retail expansion

Company's YTD operating cash flow improves to $8.5 mln from $(0.7) mln in Q3 2024

Vext strengthens Ohio retail footprint, on track for eight dispensaries by 2026

Outlook

Company expects improved Q4 cash flow as inventory is managed

Vext anticipates continued operational momentum for remainder of 2025

Result Drivers

OHIO EXPANSION - Revenue growth attributed to expanded retail operations in Ohio

ARIZONA PERFORMANCE - Steady performance in Arizona despite broader market decline

RETAIL FOOTPRINT - Strengthened Ohio retail footprint with plans for eight dispensaries by 2026

Key Details

MetricBeat/MissActualConsensus Estimate
Q3 Revenue$12.7 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell" The average consensus recommendation for the healthcare facilities & services peer group is "buy" Press Release: ID:nNFC4fr0xQ For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Vext Science

See all news